Cabozantinib 20 mg

Cabozantinib is a medication primarily used in the treatment of certain types of cancer, particularly advanced renal cell carcinoma (kidney cancer) and hepatocellular carcinoma (liver cancer). It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking the activity of specific proteins involved in cancer cell growth and spread. Cabozantinib is also used for the treatment of medullary thyroid cancer and is being studied for other types of cancer in clinical trials. It is typically taken orally in capsule form.